Australia
# |
Name |
Price to Book Ratio (P/B) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
51.03 |
Jan. 14, 2025 | USD 15.47 | 4.25% |
|
Australia |
|
2 |
18.81 |
Jan. 14, 2025 | USD 1.33 | 6.17% |
|
Australia |
|
3 |
11.08 |
Jan. 14, 2025 | USD 5.88 | 0.14% |
|
Australia |
|
4 |
9.94 |
Jan. 14, 2025 | USD 3.66 | 3.57% |
|
Australia |
|
5 |
5.09 |
Jan. 14, 2025 | USD 2.01 | -0.68% |
|
Australia |
|
6 |
4.78 |
Jan. 14, 2025 | USD 173.13 | 0.11% |
|
Australia |
|
7 |
3.91 |
Jan. 14, 2025 | USD 1.58 | -2.06% |
|
Australia |
|
8 |
3.59 |
Jan. 14, 2025 | USD 2.14 | 0.82% |
|
Australia |
|
9 |
2.69 |
Jan. 14, 2025 | USD 7.32 | 6.16% |
|
Australia |
|
10 |
1.38 |
Jan. 14, 2025 | USD 0.62 | -2.68% |
|
Australia |
The Biotechnology company in Australia with the highest Price to Book Ratio (P/B) is Telix Pharmaceuticals Limited (ASX: TLX.AX) at 51.03.
The Biotechnology company in Australia with the lowest Price to Book Ratio (P/B) is Trajan Group Holdings Limited (ASX: TRJ.AX) at 1.38.
The top 10 Biotechnology companies in Australia by Price to Book Ratio (P/B) are Telix Pharmaceuticals Limited, PolyNovo Limited, Anteris Technologies Ltd, Silex Systems Limited, Nanosonics Limited, CSL Limited, Mesoblast Limited, Australian Clinical Labs Limited, Clinuvel Pharmaceuticals Limited and Trajan Group Holdings Limited.
The bottom 10 Biotechnology companies in Australia by Price to Book Ratio (P/B) are Trajan Group Holdings Limited, Clinuvel Pharmaceuticals Limited, Australian Clinical Labs Limited, Mesoblast Limited, CSL Limited, Nanosonics Limited, Silex Systems Limited, Anteris Technologies Ltd, PolyNovo Limited and Telix Pharmaceuticals Limited.